Search research articles
Contact Us
Filters
Showing results (151-160 of 194) with videos related to
Page
of 20
Sort By:
Cancer Chemotherapy and Pharmacology
|
June 15, 2017
Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients
Jürgen Burhenne, Lu Liu, Christoph E Heilig, et al.
Frontiers in Pharmacology
|
April 24, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, et al.
Journal of Hepatology
|
May 2, 2016
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank, Christoph Markert, Nicolas Hohmann, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
January 30, 2014
Influence of St. John's wort on the steady-state pharmacokinetics and metabolism of bosentan
Christoph Markert, Prisca Ngui, Regina Hellwig, et al.
Cancers
|
June 2, 2021
Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups
Anna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, et al.
Clinical Pharmacokinetics
|
October 30, 2024
Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights
Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 20, 2023
Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers
Felicitas Stoll, Antje Blank, Gerd Mikus, et al.
British Journal of Clinical Pharmacology
|
December 12, 2018
Obesity-induced CYP2E1 activity in children
Christina Gade, Kim Dalhoff, Tonny Petersen, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 6, 2021
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies
Anna Mueller-Schoell, Lena Klopp-Schulze, Robin Michelet, et al.
Clinical Pharmacology and Therapeutics
|
March 8, 2022
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study
Michael Boettcher, Hans-Dirk Düngen, Frank Donath, et al.
Page
of 20
Search research articles
Search
Showing results (151-160 of 194) with videos related to
Sort By:
Page
of 20
Cancer Chemotherapy and Pharmacology
|
June 15, 2017
Intracellular vorinostat accumulation and its relationship to histone deacetylase activity in soft tissue sarcoma patients
Jürgen Burhenne, Lu Liu, Christoph E Heilig, et al.
Frontiers in Pharmacology
|
April 24, 2023
Evaluation of the drug-drug interaction potential of the novel hepatitis B and D virus entry inhibitor bulevirtide at OATP1B in healthy volunteers
Vanessa Zhu, Jürgen Burhenne, Johanna Weiss, et al.
Journal of Hepatology
|
May 2, 2016
First-in-human application of the novel hepatitis B and hepatitis D virus entry inhibitor myrcludex B
Antje Blank, Christoph Markert, Nicolas Hohmann, et al.
International Journal of Clinical Pharmacology and Therapeutics
|
January 30, 2014
Influence of St. John's wort on the steady-state pharmacokinetics and metabolism of bosentan
Christoph Markert, Prisca Ngui, Regina Hellwig, et al.
Cancers
|
June 2, 2021
Computational Treatment Simulations to Assess the Need for Personalized Tamoxifen Dosing in Breast Cancer Patients of Different Biogeographical Groups
Anna Mueller-Schoell, Robin Michelet, Lena Klopp-Schulze, et al.
Clinical Pharmacokinetics
|
October 30, 2024
Understanding Voriconazole Metabolism: A Middle-Out Physiologically-Based Pharmacokinetic Modelling Framework Integrating In Vitro and Clinical Insights
Ayatallah Saleh, Josefine Schulz, Jan-Frederik Schlender, et al.
European Journal of Drug Metabolism and Pharmacokinetics
|
December 20, 2023
Evaluation of Hydroxychloroquine as a Perpetrator on Cytochrome P450 (CYP) 3A and CYP2D6 Activity with Microdosed Probe Drugs in Healthy Volunteers
Felicitas Stoll, Antje Blank, Gerd Mikus, et al.
British Journal of Clinical Pharmacology
|
December 12, 2018
Obesity-induced CYP2E1 activity in children
Christina Gade, Kim Dalhoff, Tonny Petersen, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 6, 2021
Simulation-Based Assessment of the Impact of Non-Adherence on Endoxifen Target Attainment in Different Tamoxifen Dosing Strategies
Anna Mueller-Schoell, Lena Klopp-Schulze, Robin Michelet, et al.
Clinical Pharmacology and Therapeutics
|
March 8, 2022
Vericiguat in Combination with Short-Acting Nitroglycerin in Patients With Chronic Coronary Syndromes: The Randomized, Phase Ib, VENICE Study
Michael Boettcher, Hans-Dirk Düngen, Frank Donath, et al.
Page
of 20